Austin J
Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
Many men describe feeling more emotionally resilient and better able to cope with daily stressors
This is particularly beneficial for individuals who suffer from gastrointestinal issues that cause them to have difficulty absorbing food nutrients
Some people source their peptides through stateside wellness clinics that import and redistribute the substances, potentially advertising purity testing as an add-on for safer supply
The difference between approval and denial often comes down to experience and persistence, says Dr
